← FDA DRUG APPROVALS

FDA ANDA · ANDA062480

GENTACIDIN

Sponsor: NOVARTIS

APPLICATION
ANDA062480
TYPE
ANDA
ORIGINAL APPROVAL
1984-03-30
LATEST ACTION
2001-04-19
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

GENTACIDINDiscontinued
GENTAMICIN SULFATE EQ 0.3% BASE · SOLUTION/DROPS · OPHTHALMIC

Approval history

2001-04-19Manufacturing (CMC) · Supplement 9AP
1999-02-12Labeling · Supplement 7AP
1995-08-22Manufacturing (CMC) · Supplement 6AP
1994-09-30Manufacturing (CMC) · Supplement 3AP
1994-06-10Manufacturing (CMC) · Supplement 4AP
1994-05-05Labeling · Supplement 5AP
1993-08-19Labeling · Supplement 2AP
1984-03-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →